Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
3.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switching to ustekinumab biosimilars for plaque psoriasis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Exosomes in Dermatology.

Skin therapy letter·2026
Same author

Enhanced Home-Based Wart Treatment Protocol: Optimizing Debridement and Occlusion Therapy for Improved Outcomes.

Advances in skin & wound care·2026
Same author

Herpes Zoster Risk in the Era of Targeted Immunotherapy: JAK Inhibitors Versus Biologics.

Journal of cutaneous medicine and surgery·2026
Same author

Acquired Epidermodysplasia Verruciformis in Patients with Iatrogenic Immunosuppression.

Journal of clinical medicine·2026
Same author

Managing Large Nasal Defects.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Related Experiment Video

Updated: Apr 6, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

HPV Carcinomas in Immunocompromised Patients.

Nicole M Reusser1, Christopher Downing2, Jacqueline Guidry3

  • 1Medical School, the University of Texas Health Science Center at Houston, 6431 Fannin, Houston, TX 77030, USA. Nicole.M.Reusser@uth.tmc.edu.

Journal of Clinical Medicine
|August 5, 2015
PubMed
Summary

Human papillomavirus (HPV) infection is a common STD causing health issues, especially in immunocompromised individuals. HPV vaccination is the most effective prevention strategy for HPV-related diseases.

Keywords:
carcinogenesishuman Immunodeficiency virus (HIV)human papillomavirus (HPV)immunosuppressionskin cancervaccine

More Related Videos

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Related Experiment Videos

Last Updated: Apr 6, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Oncology

Background:

  • Human papillomavirus (HPV) is the most common sexually transmitted disease globally.
  • HPV infections can lead to pre-malignancies and malignancies of skin and mucosal surfaces.
  • HPV-related illnesses pose significant personal and public health challenges, particularly for immunocompromised individuals.

Purpose of the Study:

  • To review anogenital lesions in immunocompromised patients.
  • To discuss cutaneous warts and skin cancer associations in immunocompromised populations.
  • To explore HPV infections in HIV-positive and organ-transplant patients.

Main Methods:

  • Literature review of HPV-associated diseases in immunocompromised patients.
  • Analysis of current treatment options for HPV infection and manifestations.
  • Focus on primary prevention strategies, including HPV vaccination.

Main Results:

  • HPV-related malignancies disproportionately affect the immunosuppressed, including HIV-positive patients and organ-transplant recipients.
  • There is a growing incidence of HPV-associated anogenital malignancies and a decrease in the average age of affected patients.
  • Squamous cell carcinoma is the most common HPV-related malignancy.

Conclusions:

  • Primary prevention through HPV vaccination is the most effective strategy against HPV infection and related diseases.
  • Management of cutaneous disease in immunocompromised patients requires specific attention.
  • Understanding HPV's role in immunocompromised populations is crucial for public health.